Although no data support the involvement of HDAC in BCR-ABL1-dependent transformation, many authors and several clinical trials have evaluated HDAC-Is activity in CML. This evidence concerns the gene HDAC9 and chronic myelogenous leukemia, BCR-ABL1 positive.